Access to quality healthcare in developing economies continues to be constrained by structural financing gaps, particularly in the procurement and maintenance of critical medical equipment. While international health initiatives have expanded service delivery coverage, sustainable capital access for healthcare providers especially small and medium-sized enterprises (SMEs) in the private sector remains underdeveloped. This paper explores innovative financing models aimed at bridging this gap through the strategic deployment of blended finance, lifecycle asset support, and risk-sharing mechanisms. Unlike traditional health microfinance or leasing approaches, the proposed framework addresses the full spectrum of risks associated with medical asset investments, including cash flow unpredictability, lack of collateral, and equipment underutilization. Drawing upon case-based qualitative analysis and secondary data from multilateral reports, the paper presents a multi-stakeholder financing architecture. Key components include partial risk guarantees to reduce lender exposure, OEM-backed maintenance agreements to safeguard asset functionality, and cash-flow-linked repayment schemes designed to mirror provider revenue cycles. The model is further supported by reserve buffers and quality assurance mechanisms that strengthen long-term sustainability and align stakeholder incentives. Notably, this approach enhances bankability for health SMEs, reduces patient underdiagnosis due to equipment failures, and supports national goals such as Universal Health Coverage (UHC). The study contributes to the growing body of evidence advocating for health-specific, context-sensitive capital deployment strategies in LMICs. By embedding financial resilience into healthcare delivery systems, this model offers a replicable pathway to unlock new investments, improve health outcomes, and foster scalable impact in resource-constrained settings.
Oreoluwa Onabowale (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: